Skip to main content

MW 280.04 Da, Purity >99%. Potent NMDA receptor glycine site antagonist. Achieve your results faster with highly validated, pure and trusted compounds.

Be the first to review this product! Submit a review

Images

Chemical Structure - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (AB120254), expandable thumbnail
  • Functional Studies - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (AB120254), expandable thumbnail

Key facts

CAS number
1184986-70-6
Purity
> 99%
Form
Solid
Molecular weight
280.04 Da
Molecular formula
C10H4Cl2NNaO3
PubChem identifier
44134672
Nature
Synthetic

Alternative names

Recommended products

MW 280.04 Da, Purity >99%. Potent NMDA receptor glycine site antagonist. Achieve your results faster with highly validated, pure and trusted compounds.

Key facts

Purity
> 99%
PubChem identifier
44134672
Biochemical name
5,7-Dichlorokynurenic acid sodium salt
Biological description

Potent NMDA receptor glycine site antagonist.

Canonical SMILES
C1=C(C=C(C2=C1NC(=CC2=O)C(=O)[O-])Cl)Cl.[Na+]
InChI
InChI=1S/C10H5Cl2NO3.Na/c11-4-1-5(12)9-6(2-4)13-7(10(15)16)3-8(9)14;/h1-3H,(H,13,14)(H,15,16);/q;+1/p-1
InChIKey
VPRPMJHKWHCUFW-UHFFFAOYSA-M
IUPAC name
sodium;5,7-dichloro-4-oxo-1H-quinoline-2-carboxylate

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions, The product can be stored for up to 12 months

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Glutamate Receptor 1 (AMPA subtype) also known as GluR1 is a subunit of the AMPA receptor complex which mediates fast synaptic transmission in the central nervous system. It is an ionotropic receptor for glutamate functioning by opening ion channels to allow the flow of Na+ and Ca2+ ions across the cell membrane contributing to excitatory neurotransmission. The GluR1 subunit has a molecular mass of approximately 100 kDa. This receptor is commonly expressed in the brain regions such as the hippocampus and the cerebral cortex playing an important role in synaptic plasticity and memory formation.

Biological function summary

The GluR1 subunit is an essential component of the AMPA receptor complex which typically forms as a tetramer. This complex modulates synaptic strength and plasticity processes critical for learning and memory. The activity of AMPA receptors including those containing GluR1 is regulated by several auxiliary proteins and is essential for post-synaptic responses. The GluR1 subunit also interacts with other proteins such as TARPs which modulate its trafficking and channel properties.

Pathways

The GluR1-containing AMPA receptors participate significantly in the glutamatergic signaling pathway which is vital for fast excitatory synaptic transmission in the brain. This pathway also involves the NMDA receptors which work together with AMPA receptors to regulate synaptic plasticity and neuronal communication. Additionally the GluR1 interacts within the long-term potentiation (LTP) pathway contributing to the strengthening of synapses an essential mechanism underlying learning and memory.

Associated diseases and disorders

Dysfunction in GluR1 and associated AMPA receptors has been implicated in conditions like Alzheimer's disease and epilepsy. Alzheimer's disease exhibits decreased synaptic transmission and plasticity linked to impaired GluR1 function and its interactions with NMDA receptors. In epilepsy abnormal GluR1 activity may contribute to heightened neuronal excitability and seizure propagation. Targeting GluR1 or associated pathways offers potential for therapeutic interventions in these disorders possibly through drugs such as memantine and NBQX which modulate receptor activity.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (ab120254), expandable thumbnail

    Chemical Structure - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (ab120254)

    2D chemical structure image of ab120254, 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist

  • Functional Studies - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (ab120254), expandable thumbnail

    Functional Studies - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (ab120254)

    ab12416 staining cGMP in SKNSH cells treated with 5,7-Dichlorokynurenic acid sodium salt (ab120254), by ICC/IF. Decrease in cGMP expression correlates with increased concentration of 5,7-Dichlorokynurenic acid sodium salt, as described in literature.
    The cells were incubated at 37°C for 20 minutes in media containing different concentrations of ab120254 (5,7-Dichlorokynurenic acid sodium salt) in DMSO. Some samples where then further incubated with 15 µM NMDA (NMDA, excitotoxic amino acid ab120052) for 5 minutes and all samples were fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab12416 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with D

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com